Lotus Pharmaceuticals Financial Overview
Lotus Pharmaceuticals's market cap is currently $94.57K. The company's EPS TTM is $0; its P/E ratio is ―; Lotus Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.